SpectraCure's main owner subscribes in full for his share
Prior to the acquisition Masoud Khayyami, privately and with companies owned 13 227 059 shares, corresponding to 16.21% of capital and votes. Following the acquisition, Masoud Khayyami, privately and with companies owns 14 053 750 shares.
Subscription of shares supported by the warrants in the TO3 program, implies that every two (2) warrants entitles the holder to subscribe for one (1) new share in SpectraCure at the subscription price of SEK 6.50. The subscription period for SpectraCure's TO3 subscription program started Friday, November 1[st] and lasts until Friday, November 29[th]. If all warrants are fully exercised, the company cash position will increase by a total of approximately MSEK 37.1 after deduction of related issue costs.